Increasing CNS noradrenaline reduces EAE severity (Q43231220)

16 November 2017

title

Increasing CNS noradrenaline reduces EAE severity (English)

1 reference

16 November 2017

1 reference

Elena Galea

5

0 references

author name string

Maria Vittoria Simonini

1

1 reference

16 November 2017

Paul E Polak

2

1 reference

16 November 2017

Anthony Sharp

3

1 reference

16 November 2017

Susan McGuire

4

1 reference

16 November 2017

Douglas L Feinstein

6

1 reference

16 November 2017

publication date

4 December 2009

1 reference

Journal of Neuroimmune Pharmacology

16 November 2017

published in

1 reference

16 November 2017

volume

5

1 reference

16 November 2017

issue

2

1 reference

16 November 2017

page(s)

252-259

1 reference

DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)—A useful denervation tool for central and peripheral noradrenaline neurons

16 November 2017

cites work

1 reference

12 December 2020

Changes of neurotransmitter systems in chronic relapsing experimental allergic encephalomyelitis in rat brain and spinal cord

1 reference

12 December 2020

The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3,4-dihydroxyphenylalanine decarboxylation in rodent parkinsonian models.

1 reference

12 December 2020

P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis

1 reference

12 December 2020

The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats

1 reference

12 December 2020

Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor

1 reference

12 December 2020

Atomoxetine and nicotine enhance prepulse inhibition of acoustic startle in C57BL/6 mice

1 reference

12 December 2020

Noradrenergic mechanisms in neurodegenerative diseases: a theory

1 reference

12 December 2020

Changes in neurotransmitters in multiple sclerosis

1 reference

12 December 2020

In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegeneration.

1 reference

12 December 2020

Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide.

1 reference

12 December 2020

Intrinsic regulation of brain inflammatory responses.

1 reference

12 December 2020

Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis

1 reference

12 December 2020

The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines

1 reference

12 December 2020

The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents

1 reference

12 December 2020

Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B(12): mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems

1 reference

12 December 2020

Suppression of clinical weakness in experimental autoimmune encephalomyelitis associated with weight changes, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamine

1 reference

12 December 2020

Experimentally-induced neuron loss in the locus coeruleus of adult rats

1 reference

12 December 2020

MRI changes in multiple sclerosis following treatment with lofepramine and L-phenylalanine.

1 reference

12 December 2020

Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Activation of stimulatory heterotrimeric G proteins increases glutathione and protects neuronal cells against oxidative stress

1 reference

12 December 2020

L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrug

1 reference

12 December 2020

The beta 2-adrenergic agonist terbutaline suppresses acute passive transfer experimental autoimmune myasthenia gravis (EAMG)

1 reference

12 December 2020

The norepinephrine level is decreased in the lymphocytes of long-term interferon-beta-treated multiple sclerosis patients

1 reference

12 December 2020

Effects of noradrenaline on neuronal NOS2 expression and viability

1 reference

12 December 2020

Change in monoamine content and monoamine oxidase activity in brain structures during experimental allergic encephalomyelitis

1 reference

12 December 2020

Neurotransmitters, precursors and metabolites in spinal cord and brain of Lewis rats with EAE.

1 reference

12 December 2020

Locus ceruleus and immunity. II. Suppression of experimental allergic encephalomyelitis and hypersensitivity skin reactions in rats with lesioned locus ceruleus

1 reference

12 December 2020

Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Is multiple sclerosis the equivalent of Parkinson's disease for noradrenaline?

1 reference

12 December 2020

Norepinephrine depletion in the spinal cord gray matter of rats with experimental allergic encephalomyelitis

1 reference

12 December 2020

An immunocytochemical study of normal and abnormal human cerebrospinal fluid with monoclonal antibodies to glial fibrillary acidic protein.

1 reference

12 December 2020

Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems

1 reference

12 December 2020

[3H]dihydroalprenolol binding to beta adrenergic receptors in multiple sclerosis brain

1 reference

12 December 2020

Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis

1 reference

12 December 2020

beta-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1

1 reference

12 December 2020

Noradrenergic regulation of inflammatory gene expression in brain.

1 reference

12 December 2020

Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments

1 reference

12 December 2020

Beta-amyloid-dependent expression of NOS2 in neurons: prevention by an alpha2-adrenergic antagonist

1 reference

12 December 2020

Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta.

1 reference

12 December 2020

Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease.

1 reference

12 December 2020

Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression

1 reference

12 December 2020

Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats

1 reference

12 December 2020

Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression.

1 reference

12 December 2020

Effect of hypothalamic lesions on experimental autoimmune diseases in rats

1 reference

12 December 2020

Therapeutic potential of phosphodiesterase type 4 inhibition in chronic autoimmune demyelinating disease

1 reference

12 December 2020

10.1007/S11481-009-9182-2

Identifiers

DOI

1 reference

16 November 2017

1 reference